Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis
Peritoneal dialysis is a form of renal replacement alternative to the hemodialysis. During this treatment, the peritoneal membrane acts as a permeable barrier for exchange of solutes and water. Continual exposure to dialysis solutions, as well as episodes of peritonitis and hemoperitoneum, can cause...
Main Authors: | , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752998/ |
id |
pubmed-4752998 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-47529982016-03-03 Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis Strippoli, Raffaele Moreno-Vicente, Roberto Battistelli, Cecilia Cicchini, Carla Noce, Valeria Amicone, Laura Marchetti, Alessandra del Pozo, Miguel Angel Tripodi, Marco Review Article Peritoneal dialysis is a form of renal replacement alternative to the hemodialysis. During this treatment, the peritoneal membrane acts as a permeable barrier for exchange of solutes and water. Continual exposure to dialysis solutions, as well as episodes of peritonitis and hemoperitoneum, can cause acute/chronic inflammation and injury to the peritoneal membrane, which undergoes progressive fibrosis, angiogenesis, and vasculopathy, eventually leading to discontinuation of the peritoneal dialysis. Among the different events controlling this pathological process, epithelial to mesenchymal transition of mesothelial cells plays a main role in the induction of fibrosis and in subsequent functional deterioration of the peritoneal membrane. Here, the main extracellular inducers and cellular players are described. Moreover, signaling pathways acting during this process are elucidated, with emphasis on signals delivered by TGF-β family members and by Toll-like/IL-1β receptors. The understanding of molecular mechanisms underlying fibrosis of the peritoneal membrane has both a basic and a translational relevance, since it may be useful for setup of therapies aimed at counteracting the deterioration as well as restoring the homeostasis of the peritoneal membrane. Hindawi Publishing Corporation 2016 2016-01-31 /pmc/articles/PMC4752998/ /pubmed/26941801 http://dx.doi.org/10.1155/2016/3543678 Text en Copyright © 2016 Raffaele Strippoli et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Strippoli, Raffaele Moreno-Vicente, Roberto Battistelli, Cecilia Cicchini, Carla Noce, Valeria Amicone, Laura Marchetti, Alessandra del Pozo, Miguel Angel Tripodi, Marco |
spellingShingle |
Strippoli, Raffaele Moreno-Vicente, Roberto Battistelli, Cecilia Cicchini, Carla Noce, Valeria Amicone, Laura Marchetti, Alessandra del Pozo, Miguel Angel Tripodi, Marco Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis |
author_facet |
Strippoli, Raffaele Moreno-Vicente, Roberto Battistelli, Cecilia Cicchini, Carla Noce, Valeria Amicone, Laura Marchetti, Alessandra del Pozo, Miguel Angel Tripodi, Marco |
author_sort |
Strippoli, Raffaele |
title |
Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis |
title_short |
Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis |
title_full |
Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis |
title_fullStr |
Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis |
title_full_unstemmed |
Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis |
title_sort |
molecular mechanisms underlying peritoneal emt and fibrosis |
description |
Peritoneal dialysis is a form of renal replacement alternative to the hemodialysis. During this treatment, the peritoneal membrane acts as a permeable barrier for exchange of solutes and water. Continual exposure to dialysis solutions, as well as episodes of peritonitis and hemoperitoneum, can cause acute/chronic inflammation and injury to the peritoneal membrane, which undergoes progressive fibrosis, angiogenesis, and vasculopathy, eventually leading to discontinuation of the peritoneal dialysis. Among the different events controlling this pathological process, epithelial to mesenchymal transition of mesothelial cells plays a main role in the induction of fibrosis and in subsequent functional deterioration of the peritoneal membrane. Here, the main extracellular inducers and cellular players are described. Moreover, signaling pathways acting during this process are elucidated, with emphasis on signals delivered by TGF-β family members and by Toll-like/IL-1β receptors. The understanding of molecular mechanisms underlying fibrosis of the peritoneal membrane has both a basic and a translational relevance, since it may be useful for setup of therapies aimed at counteracting the deterioration as well as restoring the homeostasis of the peritoneal membrane. |
publisher |
Hindawi Publishing Corporation |
publishDate |
2016 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752998/ |
_version_ |
1613538353478631424 |